Max Robotics — Global Service Robot Directory + US Certification

About

Martin Brenier is a leading urologic oncologist whose research focuses on optimizing surgical outcomes in robot-assisted partial nephrectomy (RAPN) for kidney cancer. His work centers on three critical areas: the oncological significance of positive surgical margins, comparative surgical approaches, and the safety of outpatient management. In the landmark MARGINS study (UroCCR no 96), Brenier demonstrated that positive surgical margins after RAPN significantly impact recurrence-free and metastasis-free survival, providing crucial evidence for surgical decision-making. His multicenter PADORA study (UroCCR n° 68) compared retroperitoneal versus transperitoneal approaches, offering surgeons data-driven guidance on achieving trifecta outcomes. Most recently, his SAFE study (UroCCR 90) identified patient populations suitable for outpatient RAPN by analyzing postoperative complication timelines. With over 29 citations across these three key publications, Brenier’s work has shaped contemporary nephron-sparing surgery protocols. His contributions to the UroCCR collaborative network have advanced evidence-based practice in robotic kidney surgery, directly impacting patient selection, surgical technique, and postoperative care pathways.